AGIO Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Neutral

43

15 1 11

Oscillators

Neutral

45

5 1 4

Moving averages

Neutral

41

10 0 7

Indicator details →

Signal & events

Model signalUnavailable

EarningsOct 29, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$1.79B

Growth and income

Eps-7.01

Free Cash Flow$-267.22M

Net Income$-99.11M

Profitability

Ebitda$-470.27M

Gross Profit$19.43M

Balance sheet

Free Cash Flow$-267.22M

Total Assets$1.18B

Total Liabilities$75.88M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

IONSIONIS PHARMACEUTICALS INC+0.00%Residual co-movement · Market co-movement DNLIDENALI THERAPEUTICS INC+0.00%Residual co-movement · Market co-movement GERNGERON CORP+0.00%Residual co-movement · Market co-movement VIRVIR BIOTECHNOLOGY INC+0.00%Residual co-movement · Market co-movement RAREULTRAGENYX PHARMACEUTICAL IN+0.00%Residual co-movement · Market co-movement

RelationshipsLoading

AGIOS PHARMACEUTICALS INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships